Anti-Kallikrein 9/KLK9 Antibody Picoband® fluoro488 Vervoeging

KLK9 (kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The  KLK9  gene contains 5 coding exons and is mapped to 19q13.41. The  KLK9  gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al. (2001)   performed a quantitative analysis of  KLK9  expression in ovarian cancer. The results indicated thatKLK9  is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9  is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Kallikrein-9;3.4.21.-; Kallikrein-like protein 3; KLK-L3; KLK9

KLK9

284366

Q9UKQ9

Human

No cross-reactivity with other proteins

A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9.

Skin, thymus, trachea, cerebellum and spinal cord.

Flow Cytometry

Alzheimer's Disease, Cancer, Cell Biology, Cell Type Markers, Cytoskeleton/ECM, ECM Enzymes, Extracellular Matrix, Invasion/Microenvironment, Neurodegenerative Disease, Neurology Process, Neuroscience, Proteolysis/Ubiquitin, Proteolytic Enzymes, Signal Transduction, Tags & Cell Markers

Immunogen affinity purified.

Liquid

Key transcriptional regulator of type I interferon (IFN) -dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction. Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, is phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes. Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages.

1. Yousef, G. M., Diamandis, E. P. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9) . Genomics 65: 184-194, 2000. 2. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P., Katsaros, D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 61: 7811-7818, 2001.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

27513 MW

No cross reactivity with other proteins.

6

Kallikrein-9

Secreted .

Belongs to the peptidase S1 family. Kallikrein subfamily.

Kallikrein-9

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.